AdBoards

Getting the right people in the room is one thing, asking the right questions is another story. DeciBio can do both. Maximize the insight and impact from your advisory boards with DeciBio.

Our Experts

Katie Maloney

Andrew Aijian

Schedule a Call

Related Client Results

All Client Results

Diagnostics

NIPT Menu and Technology Offerings

A leading diagnostics player asked DeciBio to characterize the evolving NIPT market to help inform strategic positioning regarding menu offerings and technological approach

View

Voice-of-Customer Research

Pharma

Cell Therapy Market Trends and Revenue Forecast

A cell therapy developer preparing for a NASDAQ listing needed financial projections, a valuation, and support on investor messaging

View

Revenue Projection

Diagnostics

Opportunity Assessment & Target Customer Identification for In-House Hereditary Cancer Testing

A leader in research and clinical sequencing wanted to assess the market opportunity and key customer segments for an in-house hereditary cancer testing (HCT) solution

View

Customer Segmentation

Voice-of-Customer Research

Market Landscaping and Sizing

Investors

PE-Backed Life Sciences Tools Platform Development

A leading private equity firm and management team sought out DeciBio as a strategic partner to advise on the life sciences market and perform due-diligences in support of the development of a novel life sciences tools platform

View

Voice-of-Customer Research

Customer Segmentation

Pricing Strategy

Due Diligence

Competitive Analysis

Diagnostics

RNA-based Oncology Biomarker Market Landscape

A cancer diagnostics company wanted to understand the current and future landscape for RNA-based oncology biomarkers, focusing on gene expression profiling (GEP) and rearrangements across medical settings

View

Voice-of-Customer Research

Competitive Analysis

Biomarker and Diagnostics Strategy

Product Specification Mapping

Diagnostics

Low-Throughput Molecular Diagnostic Testing Landscape Assessment

A leading diagnostic company wanted an assessment of the future market landscape for low-throughput (LT) molecular diagnostic (MDx) testing to develop a long-term platform strategy to address the future needs of this market

View

Voice-of-Customer Research

Competitive Analysis

Customer Segmentation

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch